Year: 2020
Type: review
Abstract: Exosomes are extracellular vesicles released by the vast majority of cell types both in vivo and ex vivo, upon the fusion of multivesicular bodies (MVBs) with the cellular plasma membrane. Two main functions have been attributed to exosomes: their capacity to transport proteins, lipids and nucleic acids between cells and organs, as well as their potential to act as natural intercellular communicators in normal biological processes and in pathologies. From a clinical perspective, the majority of applications use exosomes as biomarkers of disease. A new approach uses exosomes as biologically active carriers to provide a platform for the enhanced delivery of cargo in vivo. One of the major limitations in developing exosome-based therapies is the difficulty of producing sufficient amounts of safe and efficient exosomes. The identification of potential proteins involved in exosome biogenesis is expected to directly cause a deliberate increase in exosome production. In this review, we summarize the current state of knowledge regarding exosomes, with particular emphasis on their structural features, biosynthesis pathways, production techniques and potential clinical applications.
Source: Journal of Clinical Medicine
DOI: 10.3390/jcm9082380
Institutions: Universidad de Granada, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, Université Mohammed VI Polytechnique, Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Instituto de Investigación Biosanitaria de Granada
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,324
Awards: G1721467449, G2661508407, G291591505, Edición génica como alternativa a los vectores retrovirales para terapia génica del síndrome de Wiskott-Aldrich, G45314348, G575896470, G6298273575, DESARROLLO DE CELLULAS T UNIVERSALES PARA SU USO EN PROTOCOLOS DE INMUNOTERAPIA DE LEUCEMIAS, G7101138294, G7921426667, Optimización de la edición genómica para su aplicación a terapia génica de enfermedades monogénicas, G8258254616, G8315701391, G8535242, G8633004816
OpenAlex ID: W3044201400
